Subscribe To Our Newsletter
Abonnez-vous à notre bulletin
ROUND EIGHT RESULTS, BY COUNTRY
GFO Issue 98

ROUND EIGHT RESULTS, BY COUNTRY

Author:

Bernard Rivers

Article Type:
News

Article Number: 2

ABSTRACT A detailed listing and analysis is provided of which Round 8 proposals have been approved.

Based on advice from the TRP, the Board divided eligible Round 8 proposals into five Categories, as follows:

  • Category 1: Approved proposals requiring no or minor clarifications, which need to be provided within 8 weeks and then given a final approval by the TRP Chair and/or Vice-Chair.
  • Category 2: Proposals that are approved in principle, subject to the required clarifications being provided within a limited timeframe (6 weeks for the applicant to provide an initial detailed response to the TRP queries, and a further 3 months to obtain the final TRP approval should further clarifications be requested). The TRP Chair and Vice-Chair need to give final approval.
  • Category 2B: Proposals that are treated as those in Category 2, but are regarded as being relatively weak, on grounds of technical merit and/or issues of feasibility and likelihood of effective implementation.
  • Category 3: Proposals not approved in their present form, though applicants are encouraged to resubmit in Round 9 following major revision.
  • Category 4: Proposals that are rejected, with applicants not encouraged to resubmit in any similar form.

 

The Board approved “in principle” (to use its precise words) all proposals in Categories 1, 2 and 2B. However, some of the approvals are immediate and some are delayed, depending on future availability of funds. The prioritization is handled as follows:

  • Category 1 proposals are approved immediately.
  • Each country submitting a Category 2 or 2B proposal is assigned a disease burden index of 4 or 1 according to whether the disease burden is “very high” or not “very high”. And each such country is assigned a poverty index of 4, 2 or 0 according to whether the country is low income, lower-middle income, or upper-middle income. The sum of these two indexes creates the Composite Index, whose value is therefore between 8 and 1. The higher the country’s Composite Index, the sooner its Category 2 or 2B proposal will be approved.
  • Category 2 proposals with a Composite Index of 8, 6 or 5 are immediately approved.
  • Remaining Category 2 and 2B proposals will be approved in the following order, as pledges by donors to the Fund become available in the course of 2008-9:

1. Category 2, Composite Index 3

2. Category 2B, Composite Index 8

3. Category 2B, Composite Index 6

4. Category 2B, Composite Index 5

5. Category 2B, Composite Index 3

 

The number of Round 8 grants per Category and Composite Index are as follows:

Table 4: Round 8 results by Category and Composite Index

 

Category and Composite Index

Number of proposals

Amount requested
(Years 1-2)

Immediate approval: Category 1

16

USD 0.45 b.

Immediate approval: Category 2, Composite Index 8, 6 or 5

43

USD 1.68 b.

Delayed approval: Category 2, Composite Index 3

8

USD 0.18 b.

Delayed approval: Category 2B, Composite Index 8

6

USD 0.44 b.

Delayed approval: Category 2B, Composite Index 6

6

USD 0.10 b.

Delayed approval: Category 2B, Composite Index 5

8

USD 0.13 b.

Delayed approval: Category 2B, Composite Index 3

7

USD 0.09 b.

Subtotal: All Approved Proposals:

94

USD 3.06 b.

Not Approved: Category 3

63

USD 1.75 b.

Not Approved: Category 4

17

USD 0.43 b.

Not Approved: Removed sub-components of approved proposals

n/a

USD 0.56 b.

Subtotal: All Non-Approved Proposals:

80

USD 2.73 b.

Total: All Proposals

174

USD 5.79 b.

 

 

Round 8 results by applicant were as in Tables 5 and 6, below.

 

Table 5: Round 8 Results, by Country

 

Country

Disease component

Applicant

Decision

Category

(defined above)

Composite Index

(defined above)

Amount requested
(Years 1-2)

Amount requested
(Years 1-5)

Afghanistan Malaria (disease part + HSS part)

CCM

Delayed approval

2B

5

EUR 30,075,545

EUR 55,397,259

Afghanistan TB

CCM

Immediate approval

1

n/a

EUR 7,394,272

EUR 22,669,094

Algeria HIV

CCM

Not approved

4

n/a

USD 15,252,168

USD 32,720,961

Angola HIV

CCM

Not approved

4

n/a

USD 75,142,046

USD 235,955,998

Angola TB

CCM

Not approved

4

n/a

USD 11,756,766

USD 25,098,444

Armenia HIV (HSS part)

CCM

Immediate approval

2

6

EUR 1,466,930

EUR 2,062,995

Armenia HIV (disease part)

CCM

Not approved

n/a

n/a

EUR 2,394,212

EUR 6,257,962

Armenia TB

CCM

Immediate approval

1

n/a

EUR 2,006,371

EUR 6,205,708

Bangladesh HIV

CCM

Not approved

3

n/a

USD 14,964,866

USD 48,892,309

Bangladesh Malaria

CCM

Not approved

3

n/a

USD 22,729,707

USD 68,436,372

Bangladesh TB (disease part + HSS part)

CCM

Immediate approval

2

8

USD 5,627,763

USD 77,430,875

Belarus HIV (disease part + HSS part)

CCM

Immediate approval

1

n/a

EUR 11,120,812

EUR 25,389,385

Belarus TB

CCM

Not approved

3

n/a

EUR 14,254,281

EUR 31,226,265

Benin Malaria

CCM

Not approved

3

n/a

EUR 26,909,499

EUR 26,909,499

Benin TB

CCM

Not approved

3

n/a

EUR 3,556,947

EUR 6,658,804

Bolivia HIV

CCM

Not approved

3

n/a

USD 7,763,930

USD 23,802,395

Bolivia Malaria

CCM

Delayed approval

2B

3

USD 6,744,407

USD 15,578,630

Bolivia TB

CCM

Not approved

4

n/a

USD 9,191,385

USD 16,777,841

Bosnia & Herzegovina HIV

CCM

Not approved

3

n/a

EUR 12,336,077

EUR 29,441,571

Bosnia & Herzegovina TB

CCM

Not approved

3

n/a

EUR 5,722,028

EUR 9,796,973

Brazil HIV

CCM

Not approved

3

n/a

EUR 9,372,000

EUR 30,000,000

Brazil Malaria

CCM

Delayed approval

2

3

EUR 20,659,117

EUR 42,023,909

Brazil TB

CCM

Not approved

3

n/a

EUR 40,191,174

EUR 80,560,970

Bulgaria TB

CCM

Delayed approval

2B

3

EUR 3,661,435

EUR 10,527,766

Burkina Faso HIV

CCM

Not approved

3

n/a

EUR 24,844,539

EUR 48,473,676

Burkina Faso Malaria

CCM

Immediate approval

2

8

EUR 53,120,303

EUR 63,203,438

Burkina Faso TB (disease part + HSS part)

CCM

Delayed approval

2B

8

EUR 12,045,997

EUR 27,167,685

Burundi HIV

CCM

Delayed approval

2B

8

USD 41,315,145

USD 159,105,087

Cambodia HIV

CCM

Not approved

3

n/a

USD 38,283,888

USD 134,514,948

Cambodia TB (disease part + HSS part)

CCM

Not approved

3

n/a

USD 11,449,113

USD 34,686,505

Cameroon HIV

CCM

Not approved

3

n/a

EUR 28,961,003

EUR 66,797,527

Cameroon TB

CCM

Not approved

3

n/a

EUR 7,015,400

EUR 13,782,656

Cape Verde HIV

CCM

Delayed approval

2

3

USD 5,321,184

USD 12,578,727

Central African Republic Malaria

CCM

Immediate approval

2

8

EUR 10,871,833

EUR 30,971,995

Central African Republic TB

CCM

Not approved

3

n/a

EUR 9,742,228

EUR 22,482,120

Chad HIV

CCM

Immediate approval

2

8

EUR 29,702,927

EUR 63,244,477

Chad TB

CCM

Delayed approval

2B

8

EUR 3,427,453

EUR 5,385,007

China HIV

CCM

Immediate approval

2

6

EUR 15,747,191

EUR 44,128,188

China Malaria

CCM

Not approved

3

n/a

EUR 29,681,060

EUR 61,332,628

China TB

CCM

Delayed approval

2B

6

EUR 24,012,517

EUR 87,664,363

Colombia HIV

CCM

Not approved

3

n/a

EUR 12,254,560

EUR 32,867,073

Colombia Malaria

CCM

Delayed approval

2

3

EUR 16,997,092

EUR 32,262,166

Colombia TB

CCM

Not approved

3

n/a

EUR 11,968,726

EUR 22,919,271

Comoros HIV

CCM

Not approved

4

n/a

EUR 1,235,586

EUR 2,229,001

Comoros Malaria (disease part)

CCM

Immediate approval

2

5

EUR 5,280,932

EUR 11,788,954

Comoros Malaria (HSS part)

CCM

Not approved

n/a

n/a

EUR 1,061,171

EUR 2,834,024

Congo (Democratic Republic of) HIV

CCM

Immediate approval

2

8

USD 79,225,696

USD 262,911,091

Congo (Democratic Republic of) Malaria

CCM

Immediate approval

2

8

USD 153,997,553

USD 393,102,357

Congo (Democratic Republic of) TB (disease part + HSS part)

CCM

Not approved

3

n/a

USD 71,422,674

USD 199,682,709

Congo (Republic of) Malaria

CCM

Delayed approval

2B

6

EUR 25,465,537

EUR 54,135,175

Congo (Republic of) TB

CCM

Delayed approval

2B

6

EUR 2,303,089

EUR 5,005,041

Cote d’Ivoire HIV (disease part + HSS part)

CCM

Not approved

3

n/a

EUR 55,758,904

EUR 142,745,182

Cote d’Ivoire Malaria

CCM

Immediate approval

2

8

EUR 139,365,869

EUR 180,298,316

Cote d’Ivoire TB

CCM

Not approved

3

n/a

EUR 7,152,767

EUR 17,886,903

Djibouti Malaria

CCM

Not approved

3

n/a

EUR 4,335,600

EUR 10,391,353

Djibouti TB

CCM

Not approved

4

n/a

EUR 3,912,029

EUR 8,688,954

Dominican Republic Malaria

CCM

Delayed approval

2

3

USD 4,492,517

USD 8,703,257

Ecuador HIV

CCM

Not approved

3

n/a

USD 14,389,246

USD 35,615,171

Ecuador Malaria

CCM

Delayed approval

2

3

USD 8,374,965

USD 15,108,812

Ecuador TB

CCM

Not approved

3

n/a

USD 14,066,522

USD 32,819,024

Eritrea HIV (disease part)

CCM

Immediate approval

2

8

USD 17,071,740

USD 45,135,676

Eritrea HIV (HSS part)

CCM

Not approved

n/a

n/a

USD 6,087,808

USD 14,939,526

Ethiopia Malaria (disease part + HSS part)

CCM

Immediate approval

1

n/a

USD 148,412,502

USD 291,064,713

Fiji TB (disease part + HSS part)

CCM

Delayed approval

2B

3

USD 4,789,119

USD 9,929,474

Gabon HIV

CCM

Immediate approval

1

n/a

EUR 6,879,029

EUR 17,006,207

Gabon Malaria

CCM

Not approved

3

n/a

EUR 5,030,319

EUR 13,851,883

Gambia HIV (disease part + HSS part)

CCM

Immediate approval

2

5

EUR 15,250,763

EUR 36,582,801

Ghana HIV

CCM

Immediate approval

2

8

USD 51,498,200

USD 99,858,800

Ghana Malaria (disease part)

CCM

Immediate approval

2

8

USD 39,639,118

USD 158,030,372

Ghana Malaria (HSS part)

CCM

Not approved

n/a

n/a

USD 4,462,500

USD 13,420,570

Guatemala HIV (disease part + HSS part)

CCM

Not approved

4

n/a

EUR 37,104,756

EUR 115,595,987

Guatemala Malaria

CCM

Not approved

3

n/a

EUR 21,586,329

EUR 41,174,990

Guinea-Bissau TB (HSS part)

CCM

Immediate approval

2

5

EUR 595,684

EUR 1,286,514

Guinea-Bissau TB (disease part)

CCM

Not approved

n/a

n/a

EUR 7,818,909

EUR 21,213,426

Guyana HIV (HSS part)

CCM

Immediate approval

2

6

USD 4,637,491

USD 10,094,303

Guyana HIV (disease part)

CCM

Not approved

n/a

n/a

USD 6,005,402

USD 18,370,517

Guyana Malaria

CCM

Not approved

3

n/a

USD 2,993,178

USD 5,573,355

Guyana TB

CCM

Delayed approval

2B

3

USD 3,087,615

USD 7,125,899

Haiti Malaria

CCM

Delayed approval

2B

5

USD 33,402,457

USD 50,046,179

Haiti TB (disease part + HSS part)

CCM

Not approved

3

n/a

USD 31,167,222

USD 59,742,348

Honduras HIV

CCM

Not approved

3

n/a

USD 5,334,334

USD 13,389,159

Honduras TB (disease part + HSS part)

CCM

Not approved

3

n/a

USD 8,031,166

USD 16,170,525

India HIV

CCM

Not approved

3

n/a

EUR 21,263,481

EUR 75,212,496

India Malaria

CCM

Not approved

3

n/a

EUR 39,883,180

EUR 100,310,326

India TB

CCM

Not approved

3

n/a

EUR 32,420,155

EUR 79,915,954

Indonesia HIV

CCM

Immediate approval

1

n/a

USD 45,384,545

USD 130,653,560

Indonesia Malaria

CCM

Delayed approval

2

3

USD 73,453,889

USD 120,092,536

Indonesia TB

CCM

Immediate approval

1

n/a

USD 28,106,251

USD 93,001,059

Iran HIV

CCM

Delayed approval

2B

6

USD 10,328,021

USD 32,354,404

Kazakhstan HIV

CCM

Not approved

3

n/a

USD 13,880,664

USD 35,851,200

Kazakhstan Malaria

CCM

Not approved

4

n/a

USD 897,612

USD 1,376,877

Kazakhstan TB

CCM

Delayed approval

2B

3

USD 37,557,518

USD 69,880,919

Kenya HIV

CCM

Not approved

4

n/a

USD 105,743,946

USD 129,929,146

Kenya Malaria

CCM

Not approved

3

n/a

USD 89,634,705

USD 200,581,638

Kenya TB (disease part + HSS part)

CCM

Not approved

3

n/a

USD 41,216,118

USD 137,406,953

Korea (Democratic People’s Republic of) HIV

CCM

Not approved

3

n/a

EUR 15,119,159

EUR 28,699,056

Korea (Democratic People’s Republic of) Malaria

CCM

Immediate approval

2

5

EUR 9,542,511

EUR 18,348,551

Korea (Democratic People’s Republic of) TB

CCM

Delayed approval

2B

5

EUR 17,686,423

EUR 47,102,407

Kyrgyz Republic HIV

Sub-CCM

Not approved

4

n/a

USD 3,560,042

USD 6,770,643

Kyrgyz Republic Malaria

CCM

Immediate approval

2

5

USD 4,530,888

USD 8,788,180

Kyrgyz Republic TB

CCM

Not approved

3

n/a

USD 7,507,988

USD 24,622,765

Lao People’s Democratic Republic HIV (disease part + HSS part)

CCM

Immediate approval

2

8

USD 9,114,326

USD 24,569,609

Lesotho HIV (disease part + HSS part)

CCM

Immediate approval

2

6

USD 39,773,696

USD 103,429,628

Lesotho TB

CCM

Delayed approval

2B

6

USD 10,967,381

USD 28,083,618

Liberia HIV (disease part + HSS part)

CCM

Immediate approval

2

8

USD 20,199,587

USD 78,235,151

Madagascar HIV

CCM

Immediate approval

2

5

USD 11,768,300

USD 36,037,600

Madagascar TB

CCM

Delayed approval

2B

5

USD 8,987,239

USD 22,797,620

Mali HIV (disease part)

CCM

Immediate approval

2

8

EUR 40,526,846

EUR 126,634,447

Mali HIV (HSS part)

CCM

Not approved

n/a

n/a

EUR 21,852,585

EUR 49,979,708

Mauritania HIV (HSS part)

CCM

Immediate approval

1

n/a

USD 2,772,376

USD 3,942,505

Mauritania HIV (disease part)

CCM

Not approved

n/a

n/a

USD 9,367,617

USD 22,266,256

Mauritius HIV

CCM

Immediate approval

1

n/a

EUR 4,052,662

EUR 7,890,632

Moldova HIV

CCM

Delayed approval

2B

6

EUR 8,606,392

EUR 16,723,816

Moldova TB

CCM

Immediate approval

1

n/a

EUR 5,281,042

EUR 13,322,904

Mozambique HIV (HSS part)

CCM

Immediate approval

2

8

USD 13,177,452

USD 34,874,346

Mozambique HIV (disease part)

CCM

Not approved

n/a

n/a

USD 39,073,131

USD 170,770,762

Mozambique Malaria

CCM

Not approved

3

n/a

USD 78,152,630

USD 210,466,897

Namibia HIV

CCM

Not approved

3

n/a

USD 64,688,284

USD 160,505,034

Nepal HIV (disease part + HSS part)

CCM

Not approved

3

n/a

USD 35,249,649

USD 90,220,063

Nicaragua HIV

CCM

Delayed approval

2

3

USD 31,385,337

USD 65,390,510

Nigeria HIV (HSS part)

CCM

Immediate approval

2

8

USD 75,055,363

USD 178,030,052

Nigeria HIV (disease part)

CCM

Not approved

n/a

n/a

USD 293,867,577

USD 831,612,641

Nigeria Malaria

CCM

Delayed approval

2B

8

USD 334,351,033

USD 599,810,494

Nigeria TB

CCM

Not approved

3

n/a

USD 42,169,586

USD 181,584,855

Pakistan HIV

CCM

Not approved

3

n/a

USD 18,636,708

USD 66,219,051

Pakistan TB

CCM

Immediate approval

2

8

USD 9,810,559

USD 26,682,133

Panama HIV

CCM

Not approved

3

n/a

USD 4,949,840

USD 13,592,440

Papua New Guinea Malaria

CCM

Immediate approval

2

5

USD 70,139,822

USD 152,252,244

Paraguay HIV (disease part)

CCM

Immediate approval

2

6

EUR 4,765,763

EUR 13,314,074

Paraguay HIV (HSS part)

CCM

Not approved

n/a

n/a

EUR 1,514,597

EUR 3,267,216

Paraguay Malaria

CCM

Not approved

3

n/a

EUR 4,403,483

EUR 8,558,518

Paraguay TB

CCM

Not approved

3

n/a

EUR 8,277,793

EUR 18,576,825

Peru HIV (disease part + HSS part)

CCM

Not approved

3

n/a

EUR 30,545,347

EUR 50,546,403

Peru TB

CCM

Immediate approval

1

n/a

EUR 11,484,622

EUR 22,229,143

Philippines HIV (disease part + HSS part)

CCM

Not approved

3

n/a

EUR 25,581,667

EUR 42,391,843

Russian Federation TB

CCM

Not approved

3

n/a

EUR 65,687,022

EUR 139,199,580

Russian Federation TB (disease part + HSS part)

Sub-CCM

Not approved

4

n/a

EUR 18,808,972

EUR 33,180,557

Rwanda HIV

CCM

Not approved

3

n/a

USD 15,591,988

USD 38,979,970

Rwanda Malaria (disease part)

CCM

Immediate approval

2

5

USD 58,567,001

USD 138,469,243

Rwanda Malaria (HSS part)

CCM

Not approved

n/a

n/a

USD 33,702,875

USD 48,541,601

Sao Tome and Principe HIV

CCM

Not approved

3

n/a

USD 568,464

USD 1,529,157

Sao Tome and Principe TB

CCM

Immediate approval

1

n/a

USD 1,132,914

USD 2,608,818

Senegal HIV (disease part + HSS part)

CCM

Not approved

3

n/a

EUR 54,507,488

EUR 136,440,454

Senegal TB

CCM

Not approved

3

n/a

EUR 6,930,243

EUR 17,791,333

Serbia HIV

CCM

Delayed approval

2

3

EUR 3,766,988

EUR 12,406,231

Solomon Islands HIV (disease part)

CCM

Not approved

n/a

n/a

USD 4,570,062

USD 10,472,323

Solomon Islands HIV (HSS part)

CCM

Delayed approval

2B

5

USD 845,725

USD 1,686,884

Solomon Islands TB

CCM

Delayed approval

2B

5

USD 3,608,714

USD 7,334,716

Somalia HIV (disease part + HSS part)

Non-CCM

Immediate approval

2

5

USD 25,669,049

USD 60,261,684

South Africa HIV

CCM

Not approved

3

n/a

USD 91,680,358

USD 259,056,796

South Africa TB

CCM

Not approved

4

n/a

USD 68,229,369

USD 194,670,986

Sri Lanka Malaria

CCM

Delayed approval

2B

3

USD 24,040,444

USD 40,915,151

Sudan (Northern Sector) TB (disease part + HSS part)

CCM

Delayed approval

2B

8

USD 17,979,663

USD 58,048,795

Sudan (Southern Sector) HIV (disease part + HSS part)

Sub-CCM

Not approved

3

n/a

USD 28,482,979

USD 124,015,542

Swaziland HIV (HSS part)

CCM

Immediate approval

2

6

USD 8,180,726

USD 15,136,442

Swaziland HIV (disease part)

CCM

Not approved

n/a

n/a

USD 49,055,285

USD 90,214,010

Swaziland Malaria

CCM

Immediate approval

1

n/a

USD 5,637,713

USD 13,880,938

Swaziland TB

CCM

Immediate approval

2

6

USD 4,785,540

USD 11,839,346

Tajikistan HIV

CCM

Immediate approval

2

8

EUR 13,264,761

EUR 34,578,129

Tajikistan Malaria

CCM

Immediate approval

2

5

EUR 5,224,796

EUR 9,615,246

Tajikistan TB (disease part + HSS part)

CCM

Immediate approval

2

5

EUR 9,840,404

EUR 17,534,572

Tanzania (United Republic of) HIV (disease part)

CCM

Immediate approval

2

8

USD 145,848,085

USD 598,106,619

Tanzania (United Republic of) HIV (HSS part)

CCM

Not approved

n/a

n/a

USD 65,422,207

USD 96,794,019

Tanzania (United Republic of) Malaria

CCM

Immediate approval

2

5

USD 111,586,404

USD 113,335,025

Thailand HIV

CCM

Immediate approval

2

6

USD 38,254,259

USD 106,123,200

Thailand TB

CCM

Immediate approval

1

n/a

USD 12,420,804

USD 30,547,583

Togo HIV

CCM

Immediate approval

2

8

EUR 31,775,839

EUR 81,340,190

Tunisia TB

CCM

Delayed approval

2B

3

USD 4,400,014

USD 7,560,548

Turkmenistan TB

CCM

Not approved

3

n/a

USD 10,649,147

USD 20,279,651

Ukraine TB

CCM

Not approved

3

n/a

USD 36,251,905

USD 94,715,697

Uruguay HIV

CCM

Not approved

3

n/a

USD 8,951,242

USD 21,393,157

Uzbekistan HIV

CCM

Not approved

3

n/a

USD 26,428,887

USD 79,669,868

Uzbekistan Malaria

CCM

Delayed approval

2B

5

USD 2,789,923

USD 6,144,821

Uzbekistan TB

CCM

Delayed approval

2B

5

USD 13,881,631

USD 56,124,183

Vietnam HIV

CCM

Immediate approval

2

8

USD 14,577,204

USD 48,693,061

West Bank and Gaza TB

Non-CCM

Immediate approval

1

n/a

EUR 972,386

EUR 2,152,074

Yemen HIV

CCM

Not approved

3

n/a

USD 6,495,225

USD 25,735,775

Yemen TB

CCM

Not approved

4

n/a

USD 6,767,022

USD 19,880,527

Zambia HIV (disease part + HSS part)

CCM

Immediate approval

1

n/a

USD 144,079,863

USD 307,273,164

Zanzibar HIV

CCM

Not approved

4

n/a

EUR 4,127,078

EUR 7,274,018

Zanzibar Malaria (disease part + HSS part)

CCM

Immediate approval

2

5

EUR 5,648,340

EUR 12,355,905

Zimbabwe HIV

CCM

Immediate approval

2

8

USD 86,821,730

USD 296,752,070

Zimbabwe Malaria (disease part + HSS part)

CCM

Immediate approval

2

5

USD 70,994,472

USD 141,316,927

Zimbabwe TB

CCM

Delayed approval

2B

8

USD 29,538,652

USD 58,298,297

 

Table 6: Round 8 results for regional applicants

 

Country

Disease

Applicant

Decision

Category
(defined above)

Composite Index
(defined above)

Requested
(Years 1-2)

Requested
(Years 1-5)

CARE (India, Nepal, Bangladesh) HIV

Regional organization

Not approved

4

n/a

EUR 14,145,331

EUR 40,817,080

CCLAB (Guatemala, El Salvador, Honduras, Nicaragua, Dom. Rep., Panama, Costa Rica, Belize) HIV

Regional Coordinating Mechanism

Not approved

4

n/a

USD 20,292,270

USD 46,811,258

COPRECOS LAC (Colombia, El Salvador, Nicaragua, Panama, Paraguay, Dom. Rep., Uruguay, Argentina, Belize, Brazil, Ecuador, Guatemala, Haiti, Honduras, Peru, Chile, Costa Rica, Venezuela) HIV

Regional organization

Not approved

3

n/a

USD 23,122,297

USD 68,666,796

GLIA (Burundi, DRC, Kenya, Rwanda, Tanzania, Uganda) HIV

Regional organization

Not approved

4

n/a

USD 10,824,037

USD 27,044,765

SADC (Angola, Botswana, Namibia, Zambia, Zimbabwe) Malaria (disease part + HSS part)

Regional Coordinating Mechanism

Not approved

3

n/a

USD 36,018,686

USD 86,985,372

Tags :

Leave a Reply

Your email address will not be published.

AIDSPAN